Synthesis and Antidepressant activity of pyrazoline based MAO-inhibitors
PDF

How to Cite

(1)
Badavath, V. N.; Kumar, A.; Jadav, S. S.; Pattnaik, A. K.; Jayaprakash, V.; Sinha, B. N. Synthesis and Antidepressant Activity of Pyrazoline Based MAO-Inhibitors. J Pharm Chem 2016, 3 (1), 1-3. https://doi.org/10.14805/jphchem.2016.art45.

Abstract

A series of nine 3-(2-hydroxyphenyl)-5-aryl-N-phenyl-4,5-dihydropyrazole-1-carbothioamide derivative s (3a-3i) that were earlier reported as potent rMAO-A inhibitors were evaluated for their antidepressant activity in Porsolt's behavioral despair test (forced swim test) and Tail Suspension test activity, among them, compounds (3e and 3h) were found to have potent antidepressant activity. Reduction in duration of immobility was significant for all the compounds in Porsolts swim test compared with tail suspension test. 3h was further evaluated for anxiolytic activity in Elevated plus maze and was found to be devoid of it.
PDF

References

Levai, A. Synthesis of Heterocyclic Compounds by the Reactions of Exocyclic ?, ??unsaturated Ketones. J Heterocycl Chem 2004, 41 (3), 299-310. http://dx.doi.org/10.1002/jhet.5570410301

Lavai, A. Synthesis of 2?pyrazolines by the Reactions of ?, ??unsaturated Aldehydes, Ketones, and Esters with Diazoalkanes, Nitrile Imines, and Hydrazines. J Heterocycl Chem 2002, 39 (1), 1-13. http://dx.doi.org/10.1002/jhet.5570390101

Lvai, A. Synthesis of Pyrazolines by the Reactions Of?, ?-Enones with Diazomethane and Hydrazines (review). Chem Heterocycl Compd 1997, 33 (6), 647-659. http://dx.doi.org/10.1007/BF02291794

Rahman, M. A.; Siddiqui, A. A. Pyrazoline Derivatives: A Worthy Insight into the Recent Advances and Potential Pharmacological Activities. Int J Pharm Sci Drug Res 2010, 2 (3), 165-175.

Kumar, S.; Bawa, S.; Drabu, S.; Kumar, R.; Gupta, H. Biological Activities of Pyrazoline Derivatives-A Recent Development. Recent Pat Antiinfect Drug Discov 2009, 4 (3), 154-163. http://dx.doi.org/10.2174/157489109789318569

Secci, D.; Carradori, S.; Bolasco, A.; Bizzarri, B.; DAscenzio, M.; Maccioni, E. Discovery and Optimization of Pyrazoline Derivatives as Promising Monoamine Oxidase Inhibitors. Curr Top Med Chem 2012, 12 (20), 2240-2257. http://dx.doi.org/10.2174/156802612805220057

Secci, D.; Bolasco, A.; Chimenti, P.; Carradori, S. The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/anticonvulsant Agents. Curr Med Chem 2011, 18 (33), 5114-5144. http://dx.doi.org/10.2174/092986711797636090

Zeller, E. A.; Barsky, J. In Vivo Inhibition of Liver and Brain Monoamine Oxidase by 1-Isonicotinyl-2-Isopropyl Hydrazine. Exp Biol Med 1952, 81 (2), 459-461. http://dx.doi.org/10.3181/00379727-81-19910

Yanez, M.; Padin, J. F.; Arranz-Tagarro, J. a; Camina, M.; Laguna, R. History and Therapeutic Use of MAO-A Inhibitors: A Historical Perspective of Mao-a Inhibitors as Antidepressant Drug. Curr Top Med Chem 2012, 12, 2275-2282. http://dx.doi.org/10.2174/156802612805220011

BLACKWELL, B.; MARLEY, E.; PRICE, J.; TAYLOR, D. Hypertensive Interactions Between Monoamine Oxidase Inhibitors and Foodstuffs. Br J Psychiatry 1967, 113 (497), 349-365. http://dx.doi.org/10.1192/bjp.113.497.349

Blackwell, B. Hypertensive Crisis due to Monoamine-Oxidase Inhibitors. Lancet 1963, 282 (7313), 849-851. http://dx.doi.org/10.1016/S0140-6736(63)92743-0

Ramachandraih, C. T.; Subramanyam, N.; Bar, K. J.; Baker, G.; Yeragani, V. K. Antidepressants: From MAOIs to SSRIs and More. Indian J Psychiatry 2011, 53 (2), 180. http://dx.doi.org/10.4103/0019-5545.82567

Youdim, M. B.; Edmondson, D.; Tipton, K. F. The Therapeutic Potential of Monoamine Oxidase Inhibitors. Nat Rev Neurosci 2006, 7 (4), 295-309. http://dx.doi.org/10.1038/nrn1883

Jayaprakash, V.; Sinha, B. N.; Ucar, G.; Ercan, A. Bioorganic & Medicinal Chemistry Letters Pyrazoline-Based Mycobactin Analogues as MAO-Inhibitors. Bioorg Med Chem Lett 2008, 18 (24), 6362-6368. http://dx.doi.org/10.1016/j.bmcl.2008.10.084

Porsolt, R. D.; Anton, G.; Blavet, N.; Jalfre, M. Behavioural Despair in Rats: A New Model Sensitive to Antidepressant Treatments. Eur J Pharmacol 1978, 47, 379-391. http://dx.doi.org/10.1016/0014-2999(78)90118-8

Steru, L.; Chermat, R.; Thierry, B.; Simon, P. The Tail Suspension Test: A New Method for Screening Antidepressants in Mice. Psychopharmacology (Berl). 1985, 85, 367-370. http://dx.doi.org/10.1007/BF00428203

Pellow, S.; File, S. E. Anxiolytic and Anxiogenic Drug Effects on Exploratory Activity in an Elevated plus-Maze: A Novel Test of Anxiety in the Rat. Pharmacol Biochem Behav 1986, 24 (3), 525-529. http://dx.doi.org/10.1016/0091-3057(86)90552-6

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.